Ocrevus
The Top Pharma List rankings are compiled from GlobalData’s pharmaceutical revenue figures, which are based on prescription medicine sales, including generics drugs. Listed below are the charts and positions for Ocrevus in this year’s pharmaceutical sales data alongside recent articles on PMLiVE featuring Ocrevus.
16
Global Revenue Ranking
23
2030 Global forecast Ranking
Recent articles on PMLiVE featuring Ocrevus
Multiple sclerosis affects more than 2.9 million people globally
Approximately 310,720 women will be diagnosed with invasive breast cancer in the US this year
The subcutaneous formulation has the same twice-yearly dosing schedule as the previously approved intravenous infusion
More than 91,000 people in England were diagnosed with HIV and accessing care in 2022
The NHS said it expects stock of the ten-minute injection to be available in the coming weeks
The injection has the same twice-yearly schedule as the previously approved intravenous infusion
The chronic neurological condition affects more than 2.8 million people worldwide
The therapy is already approved for certain MS patients as a twice-yearly intravenous infusion
The CONSONANCE trial showed treatment with Ocrevus resulted in a majority of patients experiencing no disease progression
New data comes ahead of FDA decision on company’s controversial Alzheimer’s drug aducanumab
The data was presented virtually at the American Academy of Neurology annual meeting
The drug reduces the number of confirmed relapses in MS patients
Data provided by GlobalData
GlobalData provides trusted intelligence on the world’s largest industries including Pharmaceutical and Medical Devices. With over 2,000 in-house experts, our data-driven, technology-powered approach delivers gold-standard insights to help businesses navigate complex markets and predict future trends.
Our integrated platform empowers 4,000 of the world’s largest companies—including over 70% of FTSE 100 and 60% of Fortune 100 firms—to make timely, informed decisions through unique data, expert analysis, and innovative consulting solutions.
To find out more about how our research and insights can help you, please visit https://www.globaldata.com/who-we-are/why-globaldata/
For more details on the data and methodology used to create the Top Pharma Lists, please visit PMLiVE’s Top Pharma List – Methodology